Male osteoporosis-what are the causes, diagnostic challenges, and management
Open Access
- 9 August 2022
- journal article
- research article
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 36 (3) , 101766
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate CancerNew England Journal of Medicine, 2009
- Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter StudyJournal of Bone and Mineral Research, 2009
- Osteoporosis in MenEndocrine Reviews, 2008
- A Population-Based Assessment of Rates of Bone Loss at Multiple Skeletal Sites: Evidence for Substantial Trabecular Bone Loss in Young Adult Women and MenJournal of Bone and Mineral Research, 2008
- Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025Journal of Bone and Mineral Research, 2007
- An estimate of the worldwide prevalence and disability associated with osteoporotic fracturesOsteoporosis International, 2006
- Gender Differences in Mortality After Hip Fracture: The Role of InfectionJournal of Bone and Mineral Research, 2003
- The Effect of Teriparatide [Human Parathyroid Hormone (1–34)] Therapy on Bone Density in Men With OsteoporosisJournal of Bone and Mineral Research, 2003
- Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinomaCancer, 2002
- Alendronate for the Treatment of Osteoporosis in MenNew England Journal of Medicine, 2000